Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lipid Accumulation in Hearts Transplanted From Nondiabetic Donors to Diabetic Recipients
Raffaele Marfella, Cristiano Amarelli, Francesco Cacciatore, et al.
Journal of the American College of Cardiology (2020) Vol. 75, Iss. 11, pp. 1249-1262
Open Access | Times Cited: 59

Showing 1-25 of 59 citing articles:

Heart failure in diabetes
Stanislovas S. Jankauskas, Urna Kansakar, Fahimeh Varzideh, et al.
Metabolism (2021) Vol. 125, pp. 154910-154910
Open Access | Times Cited: 134
The Diabetic Cardiomyopathy: The Contributing Pathophysiological Mechanisms
Teresa Salvatore, Pia Clara Pafundi, Raffaele Galiero, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 107
Diabetes mellitus—Progress and opportunities in the evolving epidemic
E. Dale Abel, Anna L. Gloyn, Carmella Evans‐Molina, et al.
Cell (2024) Vol. 187, Iss. 15, pp. 3789-3820
Closed Access | Times Cited: 30
Sirt5 improves cardiomyocytes fatty acid metabolism and ameliorates cardiac lipotoxicity in diabetic cardiomyopathy via CPT2 de-succinylation
Maoxiong Wu, Jing Tan, Zhengyu Cao, et al.
Redox Biology (2024) Vol. 73, pp. 103184-103184
Open Access | Times Cited: 19
Glycated ACE2 receptor in diabetes: open door for SARS-COV-2 entry in cardiomyocyte
Nunzia D’Onofrio, Lucia Scisciola, Celestino Sardu, et al.
Cardiovascular Diabetology (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 93
Ceramides and Ceramide Scores: Clinical Applications for Cardiometabolic Risk Stratification
Mika Hilvo, Vlad C. Vasile, Leslie J. Donato, et al.
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 92
Precision medicine in distinct heart failure phenotypes: Focus on clinical epigenetics
Claudio Napoli, Giuditta Benincasa, Francesco Donatelli, et al.
American Heart Journal (2020) Vol. 224, pp. 113-128
Open Access | Times Cited: 80
Effects of Metformin in Heart Failure: From Pathophysiological Rationale to Clinical Evidence
Teresa Salvatore, Raffaele Galiero, Alfredo Caturano, et al.
Biomolecules (2021) Vol. 11, Iss. 12, pp. 1834-1834
Open Access | Times Cited: 73
Sodium-glucose cotransporter-2 (SGLT2) expression in diabetic and non-diabetic failing human cardiomyocytes
Raffaele Marfella, Lucia Scisciola, Nunzia D’Onofrio, et al.
Pharmacological Research (2022) Vol. 184, pp. 106448-106448
Open Access | Times Cited: 67
Sodium/glucose cotransporter 2 (SGLT2) inhibitors improve cardiac function by reducing JunD expression in human diabetic hearts
Raffaele Marfella, Nunzia D’Onofrio, Maria Consiglia Trotta, et al.
Metabolism (2021) Vol. 127, pp. 154936-154936
Open Access | Times Cited: 65
Emerging Roles of Ceramide in Cardiovascular Diseases
Hongyang Shu, Yizhong Peng, Weijian Hang, et al.
Aging and Disease (2022) Vol. 13, Iss. 1, pp. 232-232
Open Access | Times Cited: 38
Regulation of cardiac ferroptosis in diabetic human heart failure: uncovering molecular pathways and key targets
Flobater I. Gawargi, Paras K. Mishra
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 15
Lipotoxicity as a therapeutic target in obesity and diabetic cardiomyopathy
Michinari Nakamura
Journal of Pharmacy & Pharmaceutical Sciences (2024) Vol. 27
Open Access | Times Cited: 13
PNGL reduces lipotoxicity in diabetic cardiomyopathy and activates the adiponectin pathway
Jialu Wang, Hongna Tong, Chenyang Zhang, et al.
International Immunopharmacology (2025) Vol. 151, pp. 114373-114373
Closed Access | Times Cited: 1
Cellular interplay between cardiomyocytes and non-myocytes in diabetic cardiomyopathy
Ren Jie Phang, Rebecca H. Ritchie, Derek J. Hausenloy, et al.
Cardiovascular Research (2022) Vol. 119, Iss. 3, pp. 668-690
Open Access | Times Cited: 32
Upregulation of NF-κB by USP24 aggravates ferroptosis in diabetic cardiomyopathy
Shenglin Wu, Yueran Zhou, Jiaquan Liang, et al.
Free Radical Biology and Medicine (2023) Vol. 210, pp. 352-366
Open Access | Times Cited: 16
Suppression of RCAN1 alleviated lipid accumulation and mitochondrial fission in diabetic cardiomyopathy
Songren Shu, Hao Cui, Zirui Liu, et al.
Metabolism (2024) Vol. 158, pp. 155977-155977
Open Access | Times Cited: 7
Metformin Is Associated With a Lower Risk of Atrial Fibrillation and Ventricular Arrhythmias Compared With Sulfonylureas
Anna Ostropolets, Pierre Elias, Michael V. Reyes, et al.
Circulation Arrhythmia and Electrophysiology (2021) Vol. 14, Iss. 3
Open Access | Times Cited: 38
Epigenetic Therapies for Heart Failure: Current Insights and Future Potential
Claudio Napoli, Paola Bontempo, Vittorio Palmieri, et al.
Vascular Health and Risk Management (2021) Vol. Volume 17, pp. 247-254
Open Access | Times Cited: 37
Lipotoxicity as a therapeutic target in the type 2 diabetic heart
Trang T. D. Luong, Seonbu Yang, Jaetaek Kim
Journal of Molecular and Cellular Cardiology (2025)
Closed Access
Irisin improves insulin resistance by inhibiting autophagy through the PI3K/Akt pathway in H9c2 cells
Rongjing Song, Xuecheng Zhao, Rong Cao, et al.
Gene (2020) Vol. 769, pp. 145209-145209
Closed Access | Times Cited: 38
The human aortic endothelium undergoes dose-dependent DNA methylation in response to transient hyperglycemia
Mark E. Pepin, Concetta Schiano, Marco Miceli, et al.
Experimental Cell Research (2021) Vol. 400, Iss. 2, pp. 112485-112485
Open Access | Times Cited: 32
Ferroptosis: mechanism and role in diabetes-related cardiovascular diseases
Ziyi Wang, Chao Wu, Dong Yin, et al.
Cardiovascular Diabetology (2025) Vol. 24, Iss. 1
Open Access
Identification of lipid metabolism-related genes in dapagliflozin treated rats with diabetic cardiomyopathy by bioinformatics
Xun Huang, Yunhong Wang, Rong Wan, et al.
Frontiers in Endocrinology (2025) Vol. 16
Open Access
Novel insights in the clinical management of hyperimmune patients before and after transplantation
Vincenzo Grimaldi, Martina Pagano, Giusi Moccia, et al.
Current Research in Immunology (2023) Vol. 4, pp. 100056-100056
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top